Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double Blind, Multi-Center, Phase 1 Study of a Vero Cell-Derived, Whole Virus Clade 2 H5N1 Influenza Vaccine in Healthy Subjects Aged 18 to 45 Years

NCT00783926 is registered in ClinicalTrials.gov with Alachua Government Services, Inc. as lead sponsor.

NCT NCT00783926
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00783926 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double Blind, Multi-Center, Phase 1 Study of a Vero Cell-Derived, Whole Virus Clade 2 H5N1 Influenza Vaccine in Healthy Subjects Aged 18 to 45 Years
Lead sponsor
Alachua Government Services, Inc.
Phase
Phase 1
Overall status
Completed
Start date
July 31, 2008
Completion date
July 31, 2009
Enrollment
422 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

influenza, pandemic influenza